Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

The healthcare for transgender veterans could be better with a more unified team approach.

Facial hair is crucial for transgender men's gender identity and transition.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Care for gender-dysphoric Veterans can be improved with a consistent, team-based approach.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

The critique suggests that Wilton's work unintentionally supports the very stereotypes it aims to question and calls for a broader, more inclusive approach to understanding gender.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

Gynecologists should learn about transgender care to provide the best service.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.